Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Wright, R. L. D.
and
Lynes, P. G.
1964.
Value of Continuous Drug Administration for Chronic Long-Term Mental Hospital Patients.
Canadian Psychiatric Association Journal,
Vol. 9,
Issue. 4,
p.
352.
GORDON, MAXWELL
1967.
Psychopharmacological Agents.
p.
303.
Robak, O. H.
1967.
Bivirkninger og komplikasjoner ved lang-tidsbehandling med psykofarmaka.
Nordisk Psykiatrisk Tidsskrift,
Vol. 21,
Issue. 5,
p.
363.
Hughes, J. S.
and
Little, J. Crawford
1967.
An Appraisal of the Continuing Practice of Prescribing Tranquillizing Drugs for Long-stay Psychiatric Patients.
British Journal of Psychiatry,
Vol. 113,
Issue. 501,
p.
867.
Prien, Robert F.
Cole, Jonathan O.
and
Belkin§, Naomi F.
1969.
Relapse in Chronic Schizophrenics following Abrupt Withdrawal of Tranquilizing Medication.
British Journal of Psychiatry,
Vol. 115,
Issue. 523,
p.
679.
Gottschalk, Louis A.
Gleser, Goldine C.
Cleghorn, John M.
Stone, Walter N.
and
Winget, Carolyn N.
1970.
Prediction of changes in severity of the schizophrenic syndrome with discontinuation and administration of phenothiazines in chronic schizophrenic patients: Language as a predictor and measure of change in schizophrenia.
Comprehensive Psychiatry,
Vol. 11,
Issue. 2,
p.
123.
Heaton-Ward, W. A.
1970.
Burden Research Medal and Prize.
British Journal of Psychiatry,
Vol. 117,
Issue. 537,
p.
238.
Prien, Robert F.
Levine, Jerome
and
Switalski, Richard W.
1971.
Discontinuation of Chemotherapy for Chronic Schizophrenics.
Psychiatric Services,
Vol. 22,
Issue. 1,
p.
4.
Gottfries, Carl Gerhard
1976.
Lågtidsbehandling med neuroleptika.
Nordisk Psykiatrisk Tidsskrift,
Vol. 30,
Issue. 7,
p.
491.
Lacoursiere, Roy B.
Spohn, Herbert E.
and
Thompson, Karen
1976.
Medical effects of abrupt neuroleptic withdrawal.
Comprehensive Psychiatry,
Vol. 17,
Issue. 2,
p.
285.
Kimura, Sadamu
Mitsuya, Hideaki
and
Aoki, Naosuke
1977.
Personality Modifications Due to Long-Term Psychopharmacotherapy: In Case of Chronic Schizophrenia.
Psychiatry and Clinical Neurosciences,
Vol. 31,
Issue. 2,
p.
195.
Chan, Caryle H.
Davis, John M.
Smith, Robert C.
and
Reed, Ken
1980.
Tardive Dyskinesia.
p.
511.
Baldessarini, Ross J.
and
Davis, John M.
1980.
What is the best maintenance dose of neuroleptics in schizophrenia?.
Psychiatry Research,
Vol. 3,
Issue. 2,
p.
115.
Mitchell, James E.
1981.
Discontinuation of antipsychotic drug therapy.
Psychosomatics,
Vol. 22,
Issue. 3,
p.
241.
Linden, Robert
Davis, John M.
and
Rubinstein, Joan
1984.
Guidelines for the Use of Psychotropic Drugs.
p.
151.
Peselow, E.
Angrist, B.
Sudilovsky, A.
Corwin, J.
Siekierski, J.
Trent, F.
and
Rotrosen, J.
1987.
Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia.
Psychopharmacology,
Vol. 91,
Issue. 1,
p.
80.
Dilsaver, S. C.
and
Alessi, N. E.
1988.
Antipsychotic withdrawal symptoms: Phenomenology and pathophysiology.
Acta Psychiatrica Scandinavica,
Vol. 77,
Issue. 3,
p.
241.
Hemstrom, Carl Arthur
Evans, R. Lee
and
Lobeck, Frank G.
1988.
Haloperidol Decanoate: A Depot Antipsychotic.
Drug Intelligence & Clinical Pharmacy,
Vol. 22,
Issue. 4,
p.
290.
Dilsaver, Steven C.
and
Coffman, Jeffrey A.
1988.
Antipsychotic withdrawal phenomena in the medical-surgical setting.
General Hospital Psychiatry,
Vol. 10,
Issue. 6,
p.
438.
Davis, John M.
Janicak, Philip G.
Singla, Abhin
and
Sharma, Rajiv P.
1993.
Antipsychotic Drugs and their Side-Effects.
p.
183.
eLetters
No eLetters have been published for this article.